PT90748A - Processo par a preparacao de 4-amino-3-carboxi-quinoleinas e - naftiridinas - Google Patents
Processo par a preparacao de 4-amino-3-carboxi-quinoleinas e - naftiridinasInfo
- Publication number
- PT90748A PT90748A PT90748A PT9074889A PT90748A PT 90748 A PT90748 A PT 90748A PT 90748 A PT90748 A PT 90748A PT 9074889 A PT9074889 A PT 9074889A PT 90748 A PT90748 A PT 90748A
- Authority
- PT
- Portugal
- Prior art keywords
- naftiridines
- kinoleins
- carboxy
- amino
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8807498A FR2632305B1 (fr) | 1988-06-06 | 1988-06-06 | Amino-4 aroyl-3 quinoleines et naphtyridines, leur procede de preparation et leur application en therapeutique |
FR8808025A FR2632861B1 (fr) | 1988-06-15 | 1988-06-15 | Derives d'amino-4 carboxy-3 quinoleines et naphtyridines, leur procede de preparation et leur application comme medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
PT90748A true PT90748A (pt) | 1989-12-29 |
PT90748B PT90748B (pt) | 1994-10-31 |
Family
ID=26226703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT90748A PT90748B (pt) | 1988-06-06 | 1989-06-05 | Processo par a preparacao de 4-amino-3-carboxi-quinoleinas e - naftiridinas |
Country Status (12)
Country | Link |
---|---|
US (1) | US5026711A (pt) |
EP (1) | EP0346208B1 (pt) |
JP (1) | JP2766672B2 (pt) |
KR (1) | KR910000731A (pt) |
AU (1) | AU624825B2 (pt) |
CA (1) | CA1337073C (pt) |
DE (1) | DE68914515T2 (pt) |
DK (1) | DK273689A (pt) |
ES (1) | ES2063153T3 (pt) |
IE (1) | IE63429B1 (pt) |
NZ (1) | NZ229413A (pt) |
PT (1) | PT90748B (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991014677A1 (fr) * | 1990-03-28 | 1991-10-03 | Otsuka Pharmaceutical Co., Ltd. | Derive de quinoline, medicament anti-ulcereux contenant ce derive et production de ce derive |
US5395399A (en) * | 1993-06-14 | 1995-03-07 | Sport Wrapz, Inc. | Thermal wrap for a body member |
DE4405712A1 (de) * | 1994-02-23 | 1995-08-24 | Basf Ag | Substituierte Naphthyridine und deren Verwendung |
IL117659A (en) * | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
KR0169813B1 (ko) * | 1995-07-12 | 1999-01-15 | 김종인 | 4-아미노-3-아실나프티리딘 유도체 |
WO1998049900A1 (en) * | 1997-05-07 | 1998-11-12 | Emory University | Haloisoquinoline carboxamide |
ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
ATE333281T1 (de) | 1998-12-18 | 2006-08-15 | Scios Inc | Agonisten und antagonisten von benzodiazepinrezeptoren des peripheren typs |
WO2000037085A1 (en) | 1998-12-18 | 2000-06-29 | Scios Inc. | Treatment of diseases involving cyst formation |
DE19960924C2 (de) * | 1999-12-17 | 2002-08-01 | Therapeutics Gmbh G.O.T. | Amphiphile Polyamine, deren Anwendungen |
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
FR2862301B1 (fr) * | 2003-11-17 | 2007-12-21 | Aventis Pharma Sa | Nouveau procede de preparation de quinoleines 3-fluorees |
SE0400284D0 (sv) * | 2004-02-10 | 2004-02-10 | Astrazeneca Ab | Novel compounds |
DK1773816T3 (en) | 2004-06-24 | 2015-01-26 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
US20090105272A1 (en) * | 2005-12-24 | 2009-04-23 | Grootenhuis Peter D J | Prodrugs of modulators of ABC transporters |
JP5409010B2 (ja) | 2005-12-28 | 2014-02-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | N−[2,4−ビス(1,1−ジメチルエチル)−5−ヒドロキシフェニル]−1,4−ジヒドロ−4−オキソキノリン−3−カルボキサミドの固体形態 |
TW200829555A (en) * | 2006-11-10 | 2008-07-16 | Astrazeneca Ab | Chemical compounds |
CL2008000191A1 (es) * | 2007-01-25 | 2008-08-22 | Astrazeneca Ab | Compuestos derivados de 4-amino-cinnotina-3-carboxamida; inhibidores de csf-1r quinasa; su proceso de preparacion; y su uso para tratar el cancer. |
TW200948803A (en) * | 2008-05-07 | 2009-12-01 | Astrazeneca Ab | Chemical compounds |
US8415333B2 (en) | 2009-02-24 | 2013-04-09 | Respiratorious Ab | Bronchodilating diazaheteroaryls |
NZ624460A (en) | 2009-03-20 | 2015-12-24 | Vertex Pharma | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
TWI623537B (zh) * | 2012-01-19 | 2018-05-11 | 腫瘤療法 科學股份有限公司 | 1,5-萘啶衍生物與含此之melk抑制劑 |
CN104470518A (zh) | 2012-02-27 | 2015-03-25 | 沃泰克斯药物股份有限公司 | 药物组合物及其施用 |
CA2963945C (en) | 2014-10-07 | 2023-01-10 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4324893A (en) * | 1979-04-18 | 1982-04-13 | American Home Products Corporation | 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives |
FR2581382B1 (fr) * | 1985-05-06 | 1987-06-26 | Sanofi Sa | Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes |
GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
US5034393A (en) * | 1989-07-27 | 1991-07-23 | Dowelanco | Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives |
AU634561B2 (en) * | 1989-07-27 | 1993-02-25 | Eli Lilly And Company | Naphthyridine derivatives |
-
1989
- 1989-06-02 DK DK273689A patent/DK273689A/da not_active Application Discontinuation
- 1989-06-05 KR KR1019890007791A patent/KR910000731A/ko not_active Application Discontinuation
- 1989-06-05 ES ES89401548T patent/ES2063153T3/es not_active Expired - Lifetime
- 1989-06-05 EP EP89401548A patent/EP0346208B1/fr not_active Expired - Lifetime
- 1989-06-05 DE DE68914515T patent/DE68914515T2/de not_active Expired - Fee Related
- 1989-06-05 PT PT90748A patent/PT90748B/pt not_active IP Right Cessation
- 1989-06-05 JP JP1143956A patent/JP2766672B2/ja not_active Expired - Lifetime
- 1989-06-05 CA CA000601729A patent/CA1337073C/en not_active Expired - Fee Related
- 1989-06-06 US US07/362,105 patent/US5026711A/en not_active Expired - Fee Related
- 1989-06-06 NZ NZ229413A patent/NZ229413A/en unknown
- 1989-06-06 AU AU36035/89A patent/AU624825B2/en not_active Ceased
- 1989-06-12 IE IE179789A patent/IE63429B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT90748B (pt) | 1994-10-31 |
AU3603589A (en) | 1989-12-07 |
JPH0232058A (ja) | 1990-02-01 |
JP2766672B2 (ja) | 1998-06-18 |
IE63429B1 (en) | 1995-04-19 |
CA1337073C (en) | 1995-09-19 |
DK273689A (da) | 1989-12-07 |
NZ229413A (en) | 1990-11-27 |
DK273689D0 (da) | 1989-06-02 |
DE68914515D1 (de) | 1994-05-19 |
EP0346208B1 (fr) | 1994-04-13 |
DE68914515T2 (de) | 1994-08-18 |
ES2063153T3 (es) | 1995-01-01 |
IE891797L (en) | 1989-12-06 |
AU624825B2 (en) | 1992-06-25 |
KR910000731A (ko) | 1991-01-30 |
EP0346208A1 (fr) | 1989-12-13 |
US5026711A (en) | 1991-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT90748A (pt) | Processo par a preparacao de 4-amino-3-carboxi-quinoleinas e - naftiridinas | |
PT90119A (pt) | Processo para a preparacao de um adocante | |
PT93785A (pt) | Processo para a preparacao de derivados de 3-substituido-2-oxindole | |
PT90293A (pt) | Processo para a preparacao de macrolidos | |
PT92534A (pt) | Processo para a preparacao de compostos azabiciclicos | |
PT91068A (pt) | Processo para a preparacao de compostos biarilo | |
PT91895A (pt) | Processo para a preparacao de 9h-purinas substituidas | |
PT84561B (pt) | Processo aperfeicoado para a preparacao de derivados macrolidos | |
PT89922A (pt) | Processo para a preparacao de derivados da tiazolidenodiona | |
PT91872A (pt) | Processo para a preparacao de compostos azabiciclicos | |
PT90854A (pt) | Processo para a preparacao de 1-aril-2-naftoilaminas | |
BR8906327A (pt) | Processo para a preparacao de organoclorossilanos | |
PT89545A (pt) | Processo para a preparacao de derivados da isoquinolinona | |
PT90266A (pt) | Processo para a preparacao de compostos azabiciclicos | |
PT92638A (pt) | Processo para a preparacao de poliazamacrociclos mono-n-alquilados | |
PT88181A (pt) | Processo para a preparacao de derivados aralquilaminoalcoxifenilo | |
PT92365A (pt) | Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida | |
PT93629A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina | |
PT89775A (pt) | Processo para a preparacao de derivados de isoquinolina | |
PT92539A (pt) | Processo para a preparacao de derivados de anfotericina b | |
PT91027A (pt) | Processo para a preparacao de derivados peptidicos | |
BR8903367A (pt) | Processo para a preparacao de organoclorossilanos | |
BR8902030A (pt) | Processo para a preparacao de n-fosfonometilglicina | |
PT89778A (pt) | Processo para a preparacao de um derivado de hirudina | |
PT93631A (pt) | Processo para a preparacao de derivados de tieno-triazolo-diazepina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG3A | Patent granted, date of granting |
Effective date: 19940419 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20021031 |